Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorEvren, Asaf Evrim
dc.contributor.authorTekinkoca, Sinem
dc.contributor.authorYurttaş, Leyla
dc.date.accessioned2019-10-19T14:44:25Z
dc.date.available2019-10-19T14:44:25Z
dc.date.issued2018
dc.identifier.issn1570-1808
dc.identifier.issn1875-628X
dc.identifier.urihttps://dx.doi.org/10.2174/1570180814666170619092147
dc.identifier.urihttps://hdl.handle.net/11421/13513
dc.descriptionWOS: 000423791300006en_US
dc.description.abstractBackground: Due to multi-drug, extended-drug, and pandrug resistance phenotypes, bacterial resistance to antibiotics and fungal infections are a general health issue. Particulary, increase of fungal infections due to secondary cause of human diseases have been observed. An extensive variety of benzimidazole derivatives have been characterized for their chemotherapeutic significance. Benzimidazole derivatives have received important attention because of pharmacological significance during current years, especially antimicrobial, anti-fungal, antitubercular, antioxidant, anti-Alzheimer's disease and antihypertension activities. Methods: Some N-(1H-benzimidazol-2-yl)-2-mercaptoacetamide derivatives (2a-h) were synthesised and evaluated for their antimicrobial activity. The title compounds were gained by reacting N-(1H-benzimidazol-2-yl)-2-chloroacetamide with some substituted 2-mercapto hetero-cyclic rings. The synthesised compounds were investigated for their antimicrobial activities against C. albicans (ATCC 24433), C. krusei (ATCC 6258), C. glabrata (ATCC90030), C. parapsilosis (ATCC 22019), E. coli (ATCC 25922), E. coli (ATCC 35218), E. feacalis (ATCC 51299), E. feacalis (ATCC 29212), S. aureus (ATCC 25923), K. pneumoniae (ATCC 700603), P. aeruginosa (ATCC 27853). Results: The compounds showed high antifungal activity when compared with standard drug ketoconazole. In addition, all compounds (MIC 100 mu g/mL) showed inhibitor activity against P. aeruginosa at two fold concentration of chloramphenicol (MIC 50 mu g/mL). Also, compounds 2a, 2c and 2e (MIC: 50 mu g/mL) have equal effect against E. coli (ATCC 35218) and more effective than other compounds (MIC of chloramphenicol: 100 mu g/mL). Conclusion: All compounds showed notable activity. Compounds have determined to possess higher antifungal activity than antibacterial activity. Additionally, compounds 2a with 1-methyltetrazole, 2c with benzothiazole and 2e with 6-chlorobenzothiazole moieties were found as the most active compounds.en_US
dc.language.isoengen_US
dc.publisherBentham Science Publ LTDen_US
dc.relation.isversionof10.2174/1570180814666170619092147en_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectBenzimidazoleen_US
dc.subjectAzolesen_US
dc.subjectAntifungal Activityen_US
dc.subjectAntibacterial Activityen_US
dc.subjectBacteriaen_US
dc.subjectFungien_US
dc.titleSynthesis and Antimicrobial Activity of Some New N-(1H-benzimidazol-2yl)-2-mercaptoacetamide Derivativesen_US
dc.typearticleen_US
dc.relation.journalLetters in Drug Design & Discoveryen_US
dc.contributor.departmentAnadolu Üniversitesi, Eczacılık Fakültesi, Farmasötik Kimya Anabilim Dalıen_US
dc.identifier.volume15en_US
dc.identifier.issue2en_US
dc.identifier.startpage154en_US
dc.identifier.endpage159en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.contributor.institutionauthorYurttaş, Leyla


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster